Connaughton Bernadette
CIK 0001662521
Director
Filings
19
Latest Jun 2, 2026
Issuers covered
3
Showing
19 of 19
Page 1
Track record
9 of 10 open-market trades scored (90% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 78% | +2.9% | +2.2% | +13.0% | -9.5% |
| 90 days | 8 | 75% | +3.9% | +7.1% | +11.4% | -18.3% |
| 180 days | 7 | 100% | +7.3% | +4.8% | +17.1% | +0.4% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Connaughton Bernadette has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| HALO | Halozyme Therapeutics, Inc. | 12 | Jun 2, 2026 |
| EDIT | Editas Medicine, Inc. | 4 | Jun 10, 2025 |
| SYNH | Syneos Health, Inc. | 3 | Sep 28, 2023 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|